Literature DB >> 2711819

Leptomeningeal gliomatosis with spinal cord or cauda equina compression: a complication of supratentorial gliomas in adults.

J Y Delattre1, R W Walker, M K Rosenblum.   

Abstract

Seven patients with supratentorial gliomas developed leptomeningeal gliomatosis (LMG) without symptomatic recurrence at the primary tumor site. In all, severe back and radicular pain, often simulating disc disease, preceded the development of spinal cord or cauda equina dysfunction. In 4 instances, intracranial hypertension due to hydrocephalus developed prior to spinal involvement. Cytological examination of the CSF revealed malignant cells in only 2/7 but a myelogram was diagnostic in all 7. All patients received spinal irradiation (RT) and 5 received chemotherapy. Two patients with low-grade gliomas improved transiently; 5 with malignant gliomas responded poorly, became paraplegic over 4 months and eventually died of LMG. When fatal LMG occurs in young adults suffering from supratentorial glioma, the primary tumor is often quiescent. Hydrocephalus is often the first manifestation of LMG and, when it is detected, a myelogram and CSF cytology study should be performed in the hope that diagnosis and treatment of spinal cord lesion at a very early stage will prove beneficial. Irradiation of the entire spinal canal is probably required as there is a high risk of rapid development of new lesions in non irradiated segments of the spinal canal.

Entities:  

Mesh:

Year:  1989        PMID: 2711819     DOI: 10.1111/j.1600-0404.1989.tb03725.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Treatment of meningeal gliomatosis.

Authors:  P F Pradat; K Hoang-Xuan; P Cornu; K Mokhtari; N Martin-Duverneuil; M Poisson; J Y Delattre
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

2.  Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: A case report.

Authors:  Raita Fukaya; Masatoki Ozaki; Dai Kamamoto; Yukina Tokuda; Tokuhiro Kimura; Masahito Fukuchi; Koji Fujii
Journal:  Mol Clin Oncol       Date:  2016-08-17

3.  Leptomeningeal gliomatosis as the initial presentation of gliomatosis cerebri.

Authors:  Matthew K Knox; Cynthia Ménard; Warren P Mason
Journal:  J Neurooncol       Date:  2010-02-10       Impact factor: 4.130

Review 4.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

5.  Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival.

Authors:  Akshitkumar M Mistry; Patrick D Kelly; Jean-Nicolas Gallant; Nishit Mummareddy; Bret C Mobley; Reid C Thompson; Lola B Chambless
Journal:  Neurosurgery       Date:  2019-11-01       Impact factor: 4.654

Review 6.  Diffuse primary leptomeningeal gliomatosis.

Authors:  G Davila; C Duyckaerts; J P Lazareth; M Poisson; J Y Delattre
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

7.  Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.

Authors:  M Schabet; P Ohneseit; R Buchholz; L Santo-Höltje; H Schmidberger
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

8.  Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report.

Authors:  Yoshiko Okita; Masahiro Nonaka; Toru Umehara; Yonehiro Kanemura; Yoshinori Kodama; Masayuki Mano; Shin Nakajima
Journal:  Oncol Lett       Date:  2015-02-06       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.